Jimenez-Moreno, A. Cecilia
van Overbeeke, Eline
Pinto, Cathy Anne
Smith, Ian
Sharpe, Jenny
Ormrod, James
Whichello, Chiara
de Bekker-Grob, Esther W.
Bullok, Kristin
Levitan, Bennett
Huys, Isabelle
de Wit, G. Ardine
Gorman, Grainne
Funding for this research was provided by:
Innovative Medicines Initiative (115966)
Wellcome Trust Centre for Mitochondrial Research (203105/Z/16/Z)
Wellcome Trust (203105/Z/16/B)
Article History
Accepted: 13 November 2020
First Online: 27 February 2021
Change Date: 11 May 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40271-021-00523-1
Declarations
:
: This study is part of the Patient Preferences in Benefit-Risk Assessments during the Drug Life Cycle (IMI-PREFER) project. The PREFER project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement no. 115966. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). Dr. Gorman’s work is supported by the Wellcome Trust Award (203105/Z/16/Z). Additionally, the delivery of MM Focus Groups was supported by the Wellcome Engagement Enrichment award 203105/Z/16/B.
: A. Cecilia Jimenez-Moreno, Eline van Overbeeke, Cathy Anne Pinto, Ian Smith, Jenny Sharpe, James Ormrod, Chiara Whichello, Esther W. de Bekker-Grob, Kristin Bullok, Bennett Levitan, Isabelle Huys, G. Ardine de Wit, and Grainne Gorman wish to confirm they have no known conflicts of interest associated with this publication and that any financial support facilitating this work (i.e. study grant) could not have influenced the study outcome. The views expressed are entirely those of the authors and do not necessarily reflect those from the institutions to which they are or were affiliated.
: This protocol and associated patient consent materials were reviewed and approved by the Ethics Committee at Newcastle University, UK (ref: 8840/2018).
: All authors collaborated in the conceptualization of this study and the interview guides. CJM delivered all FGDs and interviews. EvO, IH, JO and CJM created and validated the coding tree for analysis. CJM led the coding of the transcripts. IS and CW led the sociodemographic and clinical statistics. JS supported with patient recruitment and patient engagement tasks. CAP, GAdW and GG supervised the delivery of this study. CJM and EvO conceptualized the initial draft of this manuscript and all authors contributed significantly to the final version. GG is the principal investigator and grant recipient for this study.
: Material supporting the delivery of this study (i.e. interview guides and predefined ranking list) are included in this published article (and its supplementary information files). The datasets (i.e. transcripts) generated and/or analyzed during the current study are available from the corresponding author on reasonable request.